MAJIK MEDICINE

FOR IMMEDIATE RELEASE

NEW ORLEANS, LA

SETPEMBER 18, 2019

Majik Medicine announces today that its offer to settle its dispute with cbd MD (NYSE YCBD) has been declined with no counteroffer from cbd MD. Christy Peachey, Majik Medicine CEO said, “While we are disappointed that cbd MD Ltd. was unwilling to engage in settlement discussions, we are confident that we will prevail in defending our federally-registered mark, CBDMD ®.” Majik Medicine was founded in 2011 and has been marketing all-natural topicals and formulas under the brand, CBDMD® since 2016 and was awarded Federal Trademark Registration Number 5,173,264 for its line of CBD products in March 2017.

In 2018, Majik Medicine learned that cbd MD was marketing products under the name, CBD MD, and notified cbd MD by letter on September 25, 2018 informing them that Majik Medicine had a trademark on the brand CBD MD and that Majik Medicine was concerned that cbd MD’s marketing of a line of products under that name is causing confusion among consumers in the market. cbd MD offered an immaterial amount of consideration to purchase the Trademark from Majik Medicine, which Majik Medicine declined.

cbd MD then petitioned for cancellation of the trademark.

Majik Medicine is confident that its Trademark was properly awarded and that it will prevail in defending its mark.

Christy Peachey, CEO

Majik Medicine

cvergespeachey@gmail.com